Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is listed on Nasdaq, where it has traded since April 16, 2021.
- Listed On
- Nasdaq
- Listed Since
- April 16, 2021
- Employees
- 600
- Market Cap
- $2.0B
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 333 institutions reported holding RXRX, with 361.9 million shares worth $1.3 billion in aggregate. The largest reported holder was Vanguard, with 58.1 million shares worth $213.4 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Vanguard | 58,142,921 | $213M | Added 17.99% |
| BlackRock | 50,304,691 | $185M | Added 16.47% |
| ARK Invest | 41,337,632 | $152M | Added 2.8% |
| State Street | 34,706,130 | $127M | Added 21.82% |
| Baillie Gifford | 23,487,907 | $86M | Reduced 0.79% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RXRX?
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is listed on Nasdaq, where it has traded since April 16, 2021.
Who are the largest institutional holders of RXRX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RXRX were Vanguard, BlackRock and ARK Invest.
How many institutions own RXRX?
333 institutions reported a position in RXRX for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell RXRX last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for RXRX.
Every reported institutional holder, plus insider and congressional trades in RXRX, on SentiSense.